Lauren Sanchez, MD

Dr. Sanchez received her B.S and M.A in Molecular, Cell, and Developmental Biology at UCLA before attending medical school at the David Geffen School of Medicine at UCLA. She then completed her residency in Pediatrics at the Children's Hospital of Philadelphia. She was also a fellow at the Clinical Research Training Program at the NIH within the National Institutes of Allergy and Infectious Disease (NIAID), with focus on primary immunodeficiency.

Currently she is an Assistant Professor at UCSF. Her academic interests are in long-term outcomes in primary immunodeficiency, with focus on the transition of care of young adults with chronic illness due to primary immunodeficiency and immune dysregulatory disorders. She is also interested in the quality of life for patients with primary immunodeficiency and their families. Dr. Sanchez is also interested in the intersection of social determinants of health with allergy and immunology, and is working with others at UCSF Pediatric Allergy and Immunology to support initiatives to address issues such as food insecurity in food allergic patients.

Clinically, Dr. Sanchez attends on the UCSF Benioff Children's Hospital Mission Bay Pediatric Allergy and Immunology Consult service. She sees patients in the Pediatric Allergy Clinic, Pediatric Immunology Clinic, and the Primary Immune Regulatory Disorder (PIRD) Clinic. She also runs the Pediatric Primary Immunodeficiency Transition Clinic.
Education
06/2018 - Allergy and Immunology, UCSF
06/2016 - Pediatrics, Children's Hospital of Philadelphia
MD, 06/2013 - , UCLA David Geffen School of Medicine

  1. Feldman K, Aaronson K, Gu T, Ige K, Southworth E, Sanchez L, Stieglitz E. Desensitization using pegaspargase in the era of commercially available Erwinia: A single-institution report on efficacy, cost, and resource utilization. Pediatric blood & cancer 2024. PMID: 38311802


  2. Sanchez LA, Tang M, Ahmed A, Nussbaum JC, Nguyen DN, Muskat M, Chen XH, Pham MN. Transition of Care in Inborn Errors of Immunity: Outcomes of a Single-Center Quality Improvement Initiative. The journal of allergy and clinical immunology. In practice 2023. PMID: 37119980


  3. Marciano BE, Olivier KN, Folio LR, Zerbe CS, Hsu AP, Freeman AF, Filie AC, Spinner MA, Sanchez LA, Lovell JP, Parta M, Cuellar-Rodriguez JM, Hickstein DD, Holland SM. Pulmonary Manifestations of GATA2 Deficiency. Chest 2021. PMID: 34089740


  4. Sanchez LA, Maggadottir SM, Pantell MS, Lugar P, Rundles CC, Sullivan KE, USIDNET Consortium. Two Sides of the Same Coin: Pediatric-Onset and Adult-Onset Common Variable Immune Deficiency. Journal of clinical immunology 2017. PMID: 28755066


  5. Calkins KL, Sanchez LA, Tseng CH, Faull KF, Yoon AJ, Ryan CM, Le T, Shew SB. Effect of High-Dose Cysteine Supplementation on Erythrocyte Glutathione: A Double-Blinded, Randomized Placebo-Controlled Pilot Study in Critically Ill Neonates. JPEN. Journal of parenteral and enteral nutrition 2014. PMID: 25139979


  6. Goddard LM, Murphy TJ, Org T, Enciso JM, Hashimoto-Partyka MK, Warren CM, Domigan CK, McDonald AI, He H, Sanchez LA, Allen NC, Orsenigo F, Chao LC, Dejana E, Tontonoz P, Mikkola HK, Iruela-Arispe ML. Progesterone receptor in the vascular endothelium triggers physiological uterine permeability preimplantation. Cell 2014. PMID: 24485460


  7. Spinner MA, Sanchez LA, Hsu AP, Shaw PA, Zerbe CS, Calvo KR, Arthur DC, Gu W, Gould CM, Brewer CC, Cowen EW, Freeman AF, Olivier KN, Uzel G, Zelazny AM, Daub JR, Spalding CD, Claypool RJ, Giri NK, Alter BP, Mace EM, Orange JS, Cuellar-Rodriguez J, Hickstein DD, Holland SM. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood 2013. PMID: 24227816


  8. Shah SK, Hull SC, Spinner MA, Berkman BE, Sanchez LA, Abdul-Karim R, Hsu AP, Claypool R, Holland SM. What does the duty to warn require? The American journal of bioethics : AJOB 2013. PMID: 24024817